Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam.
Curtiss
Frederic R
FR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D000077239:Meloxicam; D018570:Risk Assessment; D013843:Thiazines / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam